Last reviewed · How we verify

NCT00571792

Evaluation of Airway Gene Expression in COPD and Controlled Populations

Terminated Last updated 4 December 2023
What this trial tests

trial in COPD in 42 participants. Terminated before completion.

Timeline
1 September 2006
Primary endpoint
1 February 2011
1 February 2011

Quick facts

Lead sponsorUniversity of Nebraska
StatusTerminated
Study typeOBSERVATIONAL
Enrollment42
Start date1 September 2006
Primary completion1 February 2011
Estimated completion1 February 2011
Sites1 location across United States

Conditions studied

Sponsor

University of Nebraska

Who can join

Adults 45 to 70, any sex, with COPD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To explore potential proteins that may be used to develop novel therapies for COPD. This will be accomplished by acquiring material from the lower respiratory tract via endobronchial brushings.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for COPD

Currently open trials in the same condition.

Other University of Nebraska trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00571792.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing